Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Patients with oral squamous cell carcinoma (OSCC) have severe defects in anti-tumor immune functions. Endothelial cells are potential regulators of immune cell functions and have therefore been examined to determine their role in tumor-induced immune suppression. The present studies showed that supernatants from endothelial cells exposed to OSCC-conditioned media (EndoOSCC-sup) had elevated levels of the immune suppressive products PGE2 and VEGF as compared to supernatants from endothelial cells treated with media alone (EndoMedia) or with keratinocyte-conditioned media (EndoKer-sup). Antibody neutralization of OSCC-derived VEGF prevented tumor-conditioned media from inducing endothelial cells to increase production of PGE2 and VEGF. Furthermore, treatment of T-cells with supernatants from EndoOSCC-sup resulted in diminished T-cell proliferation and decreased IFN-γ production, when compared to T-cells treated with media or supernatants from EndoMedia or EndoKer-sup controls. T-cell levels of granzyme B and perforin were reduced after treatment with supernatant from EndoOSCC-sup compared to control treatments. Addition of VEGF neutralizing antibody to the OSCC-conditioned media prevented endothelial cells from being skewed to downregulate T-cell proliferation and production of IFN-γ, perforin and granzyme B. Taken together, these studies provide support for the use of VEGF targeting therapies as an immunotherapeutic agent to block induction of immune suppressive endothelial cells in patients with OSCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
Osada, T., Chong, G., Tansik, R., Hong, T., Spector, N., Kumar, R., Hurwitz, H. I., Dev, I., Nixon, A. B., Lyerly, H. K., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0441-x · Cited by 311
Cited by
Tumor microenvironment and therapeutic response
Wu, T., & Dai, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.01.043 · Cited by 1,802
Immunological hallmarks of stromal cells in the tumour microenvironment
Turley, S. J., Cremasco, V., & Astarita, J. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3902 · Cited by 1,140
Shrimali, R. K., Yu, Z., Theoret, M. R., Chinnasamy, D., Restifo, N. P., & Rosenberg, S. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0153 · Cited by 677
Deciphering and Reversing Tumor Immune Suppression
Motz, G. T., & Coukos, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.005 · Cited by 598
The parallel lives of angiogenesis and immunosuppression: cancer and other tales
Motz, G. T., & Coukos, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3064 · Cited by 481
Metadata
- Authors
- Mulligan, J. K., Day, T. A., Gillespie, M. B., Rosenzweig, S. A., & Young, M. R. I.
- Venue
- Human Immunology
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 70
- Issue
- 6
- Pages
- 375-382
- ISSN
- 0198-8859 (ISSN-L)
- OpenAlex
- W47950149
- Cited by
- 56
- References
- 1
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions. https://app.cochat.ai/papers/10.1016/j.humimm.2009.01.014
- The paper
- Mulligan, J. K., Day, T. A., Gillespie, M. B., Rosenzweig, S. A., & Young, M. R. I. (2009). Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions. Human Immunology. https://doi.org/10.1016/j.humimm.2009.01.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.